REGISTERED NUMBER: 11321154 (England and Wales)

LAKEPHARM LTD

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

Page

Abridged Balance Sheet

1

Notes to the Financial Statements

3

FIXED ASSETS

Tangible assets

4

666

-

CURRENT ASSETS

Stocks

36,222

34,997

Debtors

118,646

91,108

Prepayments and accrued income

1,725

1,415

Cash at bank and in hand

632,250

578,785

788,843

706,305

CREDITORS

Amounts falling due within one year

128,044

134,670

NET CURRENT ASSETS

660,799

571,635

TOTAL ASSETS LESS CURRENT LIABILITIES

661,465

571,635

PROVISIONS FOR LIABILITIES

(167

)

-

ACCRUALS AND DEFERRED INCOME

(1,391

)

(2,167

)

NET ASSETS

659,907

569,468

CAPITAL AND RESERVES

Called up share capital

5

100

100

Retained earnings

659,807

569,368

SHAREHOLDERS' FUNDS

659,907

569,468

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 March 2026 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 14 September 2026 and were signed on its behalf by:

H M Patel - Director

1.	STATUTORY INFORMATION

Lakepharm Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

11321154

Registered office:

9 Fen View Court

Cambridge

Cambridgeshire

CB4 1RF

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover represents amounts (excluding value added tax) derived from the provision of goods and services to customers during the year.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

33% on cost

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Debtors and creditors

Debtors receivable / creditors payable within one year are measured at transaction price (less any impairment losses on debtors for bad and doubtful debts). Loans and other financial assets / liabilities are initially measured at transaction price and subsequently measured at amortised cost determined using the effective interest method (less any impairment losses on debtors) for bad and doubtful debts.

Any losses arising from impairment are recognised in the profit and loss account.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2025 - 6 ) .

4.	TANGIBLE FIXED ASSETS

Totals

£

COST

At 1 April 2025

627

Additions

865

At 31 March 2026

1,492

DEPRECIATION

At 1 April 2025

627

Charge for year

199

At 31 March 2026

826

NET BOOK VALUE

At 31 March 2026

666

At 31 March 2025

-

5.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2026

2025

value:

£

£

100

Ordinary

1

100

100

6.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2026 and 31 March 2025:

2026

2025

£

£

K C Chan

Balance outstanding at start of year

-

-

Amounts advanced

222

-

Amounts repaid

(156

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

66

-

H M Patel

Balance outstanding at start of year

-

-

Amounts advanced

222

-

Amounts repaid

(156

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

66

-

Interest has been charged on the directors loan balance during the year at the HMRC approved rates. There are no fixed terms for repayment.